{
    "data": [
        {
            "id": "6904c242ecb8a7000146051f",
            "title": "20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>DexCom, Inc.’s </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/DXCM\" target=\"_blank\">DXCM</a>) third-quarter 2025 revenue reached $1.209 billion, beating the analyst consensus <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">estimate of $1.179 billion</a>.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue grew 22% year-over-year on a reported basis and 20% year-over-year on an organic basis.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">U.S. revenue grew 21% and international revenue grew 22% on a reported basis and 18% on an organic basis, all on a <a href=\"https://www.benzinga.com/pressreleases/25/10/b48543162/dexcom-reports-third-quarter-2025-financial-results-and-updates-full-year-2025-guidance\" rel=\"noreferrer noopener\" target=\"_blank\">year-over-year basis</a>.</p><!--/$--><!--$--><p class=\"block core-block\">GAAP operating income was $242.5 million or 20.1% of revenue, an increase of 480 basis points compared to the third quarter of 2024.</p><!--/$--><!--$--><p class=\"block core-block\">Adjusted operating income reached<strong></strong> $272.9 million or 22.6% of reported revenue, an increase of 130 basis points from a year ago.</p><!--/$--><!--$--><p class=\"block core-block\">DexCom reported adjusted earnings of 61 cents, beating the consensus of 57 cents.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/news/legal/25/10/48473230/dexcom-faces-new-reports-of-deaths-linked-to-g7-glucose-monitor\" rel=\"noreferrer noopener\" target=\"_blank\">DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor</a></strong></p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Outlook</strong>: On Thursday, DexCom raised fiscal 2025 sales guidance from $4.60 billion-$4.63 billion to $4.63 billion-$4.65 billion, above the consensus of $4.626 billion.</p><!--/$--><!--$--><p class=\"block core-block\">The company also revised its profit margins. It expects adjusted gross profit margin of approximately 61%, operating margin of approximately 20-21%, and EBITDA margin of roughly 29-30%, compared to <a href=\"https://www.benzinga.com/pressreleases/25/07/b46737069/dexcom-reports-second-quarter-2025-financial-results-updates-full-year-2025-guidance-and-announces\" rel=\"noreferrer noopener\" target=\"_blank\">previous guidance of approximately 62%</a>, approximately 62%, and approximately 30%, respectively.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Take</strong></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">William Blair, in a Friday investor note, wrote that the lower stock price is due to hopes for U.S. sales growth and 2026 commentary below the Street.</p><!--/$--><!--$--><p class=\"block core-block\">DexCom remains near record highs for new patient additions, and with minimal pricing pressure expected next year, sales growth could approach 20%.</p><!--/$--><!--$--><p class=\"block core-block\">William Blair also expects significant margin expansion as DexCom moves beyond scrap and freight cost headwinds and benefits from the upcoming 15-day sensor launch.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“Taken together, we are buyers on the weakness with shares at 24x times 2026 EPS with earnings positioned to grow 20%,” William Blair wrote.</p><!--/$--><!--$--><p class=\"block core-block\">BTIG analyst maintains a Buy rating on DexCom and lowers the <a href=\"https://www.benzinga.com/quote/DXCM/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">price forecast from $109 to $85</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: DXCM stock is down 11.28% to $60.51 in the premarket at the last check on Friday.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/trading-ideas/long-ideas/25/10/48555150/jim-cramer-tells-investors-to-avoid-usa-rare-earth-for-now\" rel=\"noreferrer noopener\" target=\"_blank\">Jim Cramer Tells Investors To Avoid USA Rare Earth — For Now</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48560265\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Dex-com--Inc.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48560265/20-earnings-growth-potential-for-dexcom-analyst-cites-buying-opportunity",
            "pub_date": "2025-10-31 22:05:58",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904c350ecb8a7000146064d",
            "title": "nVent Electric Boosts Outlook After First &#39;Billion-Dollar Quarter&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>nVent Electric plc</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVT\" target=\"_blank\">NVT</a>), an electrical connection and protection solutions company, reported its <a href=\"https://s22.q4cdn.com/268397047/files/doc_financials/2025/q3/Q3-2025-NVT-Press-Release-FINAL.pdf\" rel=\"noreferrer noopener\" target=\"_blank\">third-quarter</a> results on Friday that topped street estimates.</p><!--/$--><!--$--><p class=\"block core-block\">The company reported adjusted earnings of 91 cents per share, up 44% from the prior year period, surpassing analysts’ expectations of 88 cents.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Net sales climbed to $1.05 billion, up 35% from a year earlier and ahead of estimates of $1.01 billion, while organic sales growth was 16% for the quarter. The company’s adjusted operating income rose 27% to $213 million.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/price-target/25/08/46835952/these-analysts-raise-their-forecasts-on-nvent-electric-after-strong-q2-earnings\" rel=\"noreferrer noopener\" target=\"_blank\">These Analysts Raise Their Forecasts On nVent Electric After Strong Q2 Earnings</a></em></strong></p><!--/$--><!--$--><p class=\"block core-block\">nVent’s free cash flow totaled $253 million, compared with $143 million in the same quarter of 2024. The company ended the quarter with cash and cash equivalents of $126.9 million.</p><!--/$--><!--$--><p class=\"block core-block\">The company’s board approved a regular quarterly cash dividend of 20 cents per share, payable on November 7, 2025.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Segment Performance</h2><!--/$--><!--$--><p class=\"block core-block\">Sales in the Systems Protection segment increased to $716 million from $477 million in the prior year, representing a 50% increase, while organic sales also increased by 23%.</p><!--/$--><!--$--><p class=\"block core-block\">The Electrical Connections segment reported sales of $338 million, up 11% from $305 million in the same period last year, with organic sales growth of 5%.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">nVent Electric raised its full-year 2025 outlook, now expecting reported sales growth of 27% to 28%, up from its prior guidance of 24% to 26%.</p><!--/$--><!--$--><p class=\"block core-block\">The company also projects adjusted earnings per share of $3.31 to $3.33, compared with the earlier range of $3.22 to $3.30. Wall Street analysts anticipate earnings of $3.29 per share from sales of $3.76 billion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">For the fourth quarter, nVent anticipates reported sales growth of 31% to 33% and organic sales growth of 15% to 17%, with an adjusted EPS forecast of between 87 cents and 89 cents. In contrast, Wall Street analysts expect an adjusted EPS of 88 cents.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>CEO Commentary</strong></h2><!--/$--><!--$--><p class=\"block core-block\"><strong>Beth Wozniak</strong>, nVent chair and chief executive officer, stated, “This was our first billion-dollar sales quarter, and we had record orders, backlog and strong cash flow. We also launched a number of new products, expanded capacity in several facilities to support data center and power utility growth, and executed on our acquisition integration playbook.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">“Our portfolio transformation is driving success, and we are raising our full-year sales and EPS guidance to reflect our record third quarter performance and our significant momentum in data centers. I want to recognize the hard work and dedication of our nVent team to deliver these outstanding results,” he added.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Price Action</strong>: NVT shares were trading higher by 10.68% to $115.49 at last check Friday.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48560560\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/analyst-stock-ratings/price-target/25/10/48555675/western-digital-analysts-boost-their-forecasts-after-better-than-expected-q1-results\" rel=\"noreferrer noopener\" target=\"_blank\">Western Digital Analysts Boost Their Forecasts After Better-Than-Expected Q1 Results</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by T. Schneider via Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Stuttgart--Germany---12-09-2024-Person-H.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48560560/nvent-electric-boosts-outlook-after-first-billion-dollar-quarter",
            "pub_date": "2025-10-31 22:10:28",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904a395ecb8a7000145effe",
            "title": "Top 2 Health Care Stocks That May Fall Off A Cliff This Quarter",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">As of Oct. 31, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p><!--/$--><!--$--><p class=\"block core-block\">The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href=\"https://www.benzinga.com/topic/rsi\" target=\"_blank\">RSI is above 70</a>, according to <a href=\"https://pro.benzinga.com/\" target=\"_blank\">Benzinga Pro</a>. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Here's the latest list of major overbought players in this sector.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\"><strong>Alphatec Holdings Inc (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ATEC\" target=\"_blank\">ATEC</a>)</strong></h3><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>On Oct. 30, Alphatec Holdings reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates. “I’m eXtremely proud of the entire ATEC team for delivering another quarter of industry-leading results,” said Pat Miles, Chairman and Chief Executive Officer. The company's stock gained around 12% over the past month and has a 52-week high of $17.14.</li>\n<li><strong>RSI Value:</strong> 82.5                                </li>\n<li><strong>ATEC Price Action:</strong> Shares of Alphatec fell 1% to close at $16.33 on Thursday.</li>\n<li>Edge Stock Ratings: 91.00 Momentum score.</li>\n</ul><!--/$--><!--$--><!--/$--><!--$--><h3 class=\"wp-block-heading\"><strong>Travere Therapeutics Inc (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/TVTX\" target=\"_blank\">TVTX</a>)</strong></h3><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>On Oct. 30, Travere Therapeutics reported better-than-expected third-quarter sales results. “We delivered outstanding commercial performance in the third quarter, reflecting the growing role of FILSPARI as a foundational therapy in IgAN. This success underscores the strength of our commercial execution and the expanding confidence in FILSPARI among physicians and patients,” said Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics. The company's stock gained around 24% over the past month and<a href=\"https://www.benzinga.com/quote/TVTX\" target=\"_blank\"> has a 52-week high</a> of $30.97.</li>\n<li><strong>RSI Value:</strong> 80.9</li>\n<li><strong>TVTX Price Action:</strong> Shares of Travere Therapeutics fell 1.1% to close at $29.65 on Thursday.    </li>\n</ul><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\">How do other stocks rank? Get the full <a href=\"https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound\" target=\"_blank\">BZ Edge Rankings breakdown here</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Read This Next: </strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48524289/jim-cramer-likes-toast-but-isnt-buying-shares-yet\" target=\"_blank\">Jim Cramer Likes Toast, But Isn’t Buying Shares—Yet</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48555015\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Healthcare-Funding-Pressure.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/short-ideas/25/10/48555015/top-2-health-care-stocks-that-may-fall-off-a-cliff-this-quarter",
            "pub_date": "2025-10-31 19:55:05",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904a46becb8a7000145f016",
            "title": "Bitcoin Reclaims $110,000 After Bloody Thursday For Ethereum, XRP, Dogecoin",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/money/bitcoin-price-prediction-oct-14\" target=\"_blank\">Bitcoin has reclaimed</a> the $110,000 level after four straight days of losses caused $872.33 million across 218,161 traders on Thursday.</p><!--/$--><!--$--><p class=\"block core-block\"> Spot ETFs saw heavy outflows, with Bitcoin funds losing $488.4 million and Ethereum funds $184.3 million.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Eyes Glued!</strong></p><!--/$--><!--$--><p class=\"block core-block\">Ted Pillows <a href=\"https://x.com/TedPillows/status/1984190105418875284\" target=\"_blank\">noted</a> that Bitcoin briefly fell below $107,000 before reclaiming it, though it continues to struggle above $110,000, a sign of potential weakness. </p><!--/$--><!--$--><p class=\"block core-block\">A move above $112,000 is needed to spark a broader recovery, while failure to do so could risk a drop below $100,000.</p><!--/$--><!--$--><p class=\"block core-block\">Lennaert Snyder <a href=\"https://x.com/LennaertSnyder/status/1984176403328405573\" target=\"_blank\">highlighted</a> that Bitcoin swept liquidity under $106,667 before rebounding. </p><!--/$--><!--$--><div class=\"sc-gQfuga iaHpuj\"></div><!--/$--><!--$--><p class=\"block core-block\">He sees $111,300 as the next key resistance level, a zone to watch for potential short setups on rejection or long entries if reclaimed. </p><!--/$--><!--$--><p class=\"block core-block\">A higher low near $108,160 is possible but considered risky.</p><!--/$--><!--$--><p class=\"block core-block\">Michael van de Poppe <a href=\"https://x.com/CryptoMichNL/status/1984195138403680753\" target=\"_blank\">observed</a> that Ethereum is positioned for accumulation, testing its 20-week moving average in confluence with strong higher-timeframe support. He suggests this area presents a compelling long-term opportunity, noting that \"corrections don't last forever.\"</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Crypto chart analyst Ali Martinez <a href=\"https://x.com/ali_charts/status/1983987772579786921\" target=\"_blank\">expects</a> Solana to maintain its bullish outlook as long as it holds the $190 support. Staying above this level could fuel a rebound toward $240 and potentially $300.</p><!--/$--><!--$--><p class=\"block core-block\">Trader CW <a href=\"https://x.com/CW8900/status/1984181168896626738\" target=\"_blank\">pointed</a> out that XRP currently faces two short-term selling walls. If these are cleared, there's minimal resistance until the $3 mark, opening room for a sharp upside move.</p><!--/$--><!--$--><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The meme coin market cap fell 4.5% in the past 24 hours to $60.7 billion, underperforming the broader crypto market. Frog-themed coins led the decline with an 8.3% drop, followed by Solana-based meme coins down 7.7%.</p><!--/$--><!--$--><p class=\"block core-block\">Analyst Martinez <a href=\"https://x.com/ali_charts/status/1984168966315802871\" target=\"_blank\">noted</a> that around 440 million DOGE were sold within 72 hours, indicating significant whale activity.</p><!--/$--><!--$--><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48555037\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48540185/jpmorgan-ceo-jamie-dimon-once-called-bitcoin-a-pet-rock-now-he-says-crypto-stablecoins-are-real-well-all-use-them\" target=\"_blank\">JPMorgan CEO Jamie Dimon Once Called Bitcoin A ‘Pet Rock’ — Now He Says Crypto, Stablecoins Are ‘Real, We’ll All Use Them’</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Bitcoin-With-Golden-Stars-Showering-Down_2.jpeg",
            "link": "https://www.benzinga.com/crypto/cryptocurrency/25/10/48555037/bitcoin-reclaims-110000-after-bloody-thursday-for-ethereum-xrp-dogecoin",
            "pub_date": "2025-10-31 19:58:39",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6904beb2ecb8a70001460218",
            "title": "Nasdaq Surges Over 1%; Apple Earnings Top Views",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\">U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 1% on Friday.</p><!--/$--><!--$--><p class=\"block core-block\">Following the market opening Friday, the Dow traded up 0.09% to 47,563.80 while the NASDAQ rose 1.23% to 23,871.37. The S&amp;P 500 also rose, gaining, 0.58% to 6,862.07.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Check This Out: <a href=\"https://www.benzinga.com/trading-ideas/dividends/25/10/48556132/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-with-over-6-dividend-yields-2\" target=\"_blank\">Wall Street’s Most Accurate Analysts Spotlight On 3 Industrials Stocks With Over 6% Dividend Yields</a></p><!--/$--><!--$--><p class=\"block core-block\"><strong>Leading and Lagging Sectors</strong><br/><br/>Consumer discretionary shares jumped by 4.3% on Friday.</p><!--/$--><!--$--><p class=\"block core-block\">In trading on Friday, materials stocks fell by 1.1%.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Top Headline</strong></p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Apple Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AAPL\" target=\"_blank\">AAPL</a>) reported better-than-expected financial results for the fourth quarter of fiscal 2025 on Thursday after the close.</p><!--/$--><!--$--><p class=\"block core-block\">Apple reported fiscal fourth-quarter revenue of $102.47 billion, beating analyst estimates of $102.17 billion. The tech giant reported fourth-quarter earnings of $1.85 per share, beating analyst estimates of $1.76 per share.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Equities Trading UP<br/>           </strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPWK Holdings Ltd. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/EPWK\" target=\"_blank\">EPWK</a>) shares shot up 137% to $0.1559.</li>\n<li>Shares of <strong>Getty Images Holdings, Inc. </strong>(NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/GETY\" target=\"_blank\">GETY</a>) got a boost, surging 45% to $2.93 after the company announced a multi-year licensing agreement with Perplexity AI to display Getty Images across Perplexity’s search and discovery tools.</li>\n<li><strong>MSP Recovery, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MSPR\" target=\"_blank\">MSPR</a>) shares were also up, gaining 77% to $0.56.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>Equities Trading DOWN</strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Luminar Technologies, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/LAZR\" target=\"_blank\">LAZR</a>) shares dropped 34% to $1.3801 after the company announced it received a subpoena form the SEC. Also, the company announced it is suspending its FY25 guidance.</li>\n<li>Shares of <strong>Intensity Therapeutics, Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/INTS\" target=\"_blank\">INTS</a>) were down 28% to $0.95 after the company reported pricing of $4 million registered direct offering of common stock.</li>\n<li><strong>OneSpan Inc. </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/OSPN\" target=\"_blank\">OSPN</a>) was down, falling 26% to $11.52 after the company reported worse-than-expected third-quarter sales results and cut its FY25 sales guidance below estimates. Also, Rosenblatt cut its price target from $17 to $15 on the stock.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>Commodities</strong><br/><br/>In commodity news, oil traded up 0.7% to $61.04 while gold traded up 0.4% at $4,031.90.</p><!--/$--><!--$--><p class=\"block core-block\">Silver traded down 0.3% to $48.485 on Friday, while copper fell 0.4% to $5.0860.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Euro zone</strong></p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">European shares were lower today. The eurozone's STOXX 600 slipped 0.5%, while Spain's IBEX 35 Index fell 0.1%. London's FTSE 100 fell 0.4%, Germany's DAX 40 fell 0.5% and France's CAC 40 fell 0.4% during the session.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Asia Pacific Markets</strong></p><!--/$--><!--$--><p class=\"block core-block\">Asian markets closed mostly lower on Friday, with Japan's Nikkei 225 gaining 2.12%, Hong Kong's Hang Seng falling 1.43%, China's Shanghai Composite dipping 0.81% and India's BSE Sensex declining 0.55%.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Economics</strong></p><!--/$--><!--$--><p class=\"block core-block\">The Baker Hughes oil rig count report for the latest week will be released today.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Now Read This: </strong></p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/trading-ideas/dividends/25/10/48555721/how-to-earn-500-a-month-from-clorox-stock-ahead-of-q1-earnings\" target=\"_blank\">How To Earn $500 A Month From Clorox Stock Ahead Of Q1 Earnings</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\">Photo via Shutterstock</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48559499\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/31/Nasdaq-rising.jpeg",
            "link": "https://www.benzinga.com/markets/market-summary/25/10/48559499/nasdaq-surges-over-1-apple-earnings-top-views",
            "pub_date": "2025-10-31 21:50:46",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}